Des Richardson
Des Richardson
Verified email at sydney.edu.au
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ...
Autophagy 12 (1), 1-222, 2016
8486*2016
The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells
DR Richardson, P Ponka
Biochimica Et Biophysica Acta (BBA)-Reviews on Biomembranes 1331 (1), 1-40, 1997
7341997
The evolution of iron chelators for the treatment of iron overload disease and cancer
DS Kalinowski, DR Richardson
Pharmacological reviews 57 (4), 547-583, 2005
7152005
Function and regulation of transferrin and ferritin.
P Ponka, C Beaumont, DR Richardson
Seminars in hematology 35 (1), 35-54, 1998
6341998
The role of iron in cell cycle progression and the proliferation of neoplastic cells
NTV Le, DR Richardson
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1603 (1), 31-46, 2002
4822002
A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics
M Whitnall, J Howard, P Ponka, DR Richardson
Proceedings of the National Academy of Sciences 103 (40), 14901-14906, 2006
4452006
Iron uptake and metabolism in the new millennium
LL Dunn, YS Rahmanto, DR Richardson
Trends in cell biology 17 (2), 93-100, 2007
4422007
Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol
DR Richardson, DJR Lane, EM Becker, MLH Huang, M Whitnall, ...
Proceedings of the National Academy of Sciences 107 (24), 10775-10782, 2010
3702010
Novel di-2-pyridyl–derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment
J Yuan, DB Lovejoy, DR Richardson
Blood 104 (5), 1450-1458, 2004
3562004
The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents
DR Richardson, EH Tran, P Ponka
3441995
Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity
DR Richardson, PC Sharpe, DB Lovejoy, D Senaratne, DS Kalinowski, ...
Journal of medicinal chemistry 49 (22), 6510-6521, 2006
3332006
Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors
Y Yu, DS Kalinowski, Z Kovacevic, AR Siafakas, PJ Jansson, C Stefani, ...
Journal of medicinal chemistry 52 (17), 5271-5294, 2009
3252009
Iron trafficking in the mitochondrion: novel pathways revealed by disease
I Napier, P Ponka, DR Richardson
Blood 105 (5), 1867-1874, 2005
3002005
Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and …
NTV Le, DR Richardson
Blood 104 (9), 2967-2975, 2004
2732004
Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents
DR Richardson, DS Kalinowski, S Lau, PJ Jansson, DB Lovejoy
Biochimica et Biophysica Acta (BBA)-General Subjects 1790 (7), 702-717, 2009
2692009
Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and-sensitive parasites
A Walcourt, M Loyevsky, DB Lovejoy, VR Gordeuk, DR Richardson
The international journal of biochemistry & cell biology 36 (3), 401-407, 2004
2612004
Iron chelators as therapeutic agents for the treatment of cancer
DR Richardson
Critical reviews in oncology/hematology 42 (3), 267-281, 2002
2332002
Unraveling the mysteries of serum albumin—more than just a serum protein
AM Merlot, DS Kalinowski, DR Richardson
Frontiers in physiology 5, 299, 2014
2322014
The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: the mechanisms involved in inhibiting cell-cycle …
J Gao, DR Richardson
Blood, The Journal of the American Society of Hematology 98 (3), 842-850, 2001
2322001
Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and …
TB Chaston, DB Lovejoy, RN Watts, DR Richardson
Clinical cancer research 9 (1), 402-414, 2003
2292003
The system can't perform the operation now. Try again later.
Articles 1–20